Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Aerie

Aerie built a $2 billion brand by rejecting Victoria’s Secret’s old playbook. Now it wants to win the AI backlash

An ad featuring Pamela Anderson offers an update to the brand’s body-positive ethos for the AI era.

Fortune

North Carolina woman tries on bathing suits in Aerie. Then she catches the worker talking about her behind her back: ‘I’m literally in tears’

A new mom goes swimsuit shopping at the Greensboro, North Carolina, Aerie and apologizes in advance for how many items she brings to the dressing room. Then, she overhears the worker speaking badly about her when she brings one more item back.

The Mary Sue

Pamela Anderson’s newest venture protests AI models — and fans are thrilled

The actor partnered with Aerie, which has vowed not to use any AI-generated imagery in its marketing

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Pamela Anderson's Aerie Campaign Is Her Response to AI's "Unsettling" Hold On the Fashion Industry

She's found another way to show up as her unfiltered, unaltered self.

Marie Claire

Sydney Sweeney Made American Eagle Stock a Star in 2025. Should You Keep Buying AEO in 2026?

American Eagle has converted pop-culture momentum into category-leading stock performance. Does this success leave room for further upside next year?

Barchart

American Eagle Analysts Bullish On Aerie Inflection, Brand Recovery

American Eagle Outfitters (NYSE:AEO) shares are trading higher after the company reported better-than-expected third-quarter results on Tuesday.

Benzinga

American Eagle Outfitters Stock Smashes 52-Week High On Holiday Momentum

American Eagle Outfitters (NYSE:AEO) stock reached a new 52-week high after the retailer reported strong third-quarter results and signaled a sharp demand rebound heading into the holiday season.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Luxury Services That Only Cater To the 1% — and How Much They Would Cost You

The average American household can't pay for the kinds of services that the wealthiest 1% spend on. Here are the approximate costs of some of those services.

GOBankingRates

Tariff Pressures Loom Over American Eagle's Outlook Despite Recent Gains

Retailers are navigating a complex landscape marked by shifting consumer preferences and economic uncertainties, prompting them to adapt strategies for sustained growth. Amid these challenges, American Eagle Outfitters, Inc. (NYSE:AEO) has shown resilience by outperforming financial expectations, even as broader market trends pose ongoing hurdles.

Benzinga

Sydney Sweeney Couldn’t Save American Eagle Stock. Here’s Why Analysts Think You Should Ditch AEO Here.

American Eagle is a beaten-down stock that trades over 60% below its all-time high in August 2025. Can AEO stock recover over the next 12 months?

Barchart

Is The Sydney Sweeney Boost Already Fading For American Eagle Stock?

American Eagle Outfitters Inc. (NYSE:AEO) shares slipped Monday after fresh concerns emerged over slowing sales momentum, tariff headwinds, and limited earnings visibility, raising doubts about the retailer’s ability to sustain its recent buzz from celebrity-driven marketing and denim demand.

Benzinga

Hanesbrands vs. American Eagle Outfitters: Which Apparel Retail Stock Should You Consider?

The apparel retail industry is thriving due to the growing consumer demand for premium products. Amid this, let’s compare apparel stocks Hanesbrands (HBI) and American Eagle Outfitters (AEO) to analyze which apparel retail stocks should one consider. Read on to find out….

StockNews.com

3 Apparel Brands Gaining Popularity Among Millennials

The apparel industry is thriving, fueled by millennial-driven trends like sustainability, digital-first shopping habits, and increasing discretionary spending. Against this dynamic backdrop, fundamentally robust stocks like Abercrombie & Fitch (ANF), American Eagle Outfitters (AEO), and Revolve Group (RVLV) are not only resonating with this influential demographic but also emerging as…

StockNews.com

American Eagle Sues Amazon Over Alleged Sale Of Aerie 'Knock-offs'

American Eagle has filed a suit against Amazon after allegedly selling knock-offs of its Aerie products.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

Marie Claire

I Spent 24 Hours With The Industry's Top Leaders—Here's How It Went

Inspired to a new level.

The Independent UK

Gen-Z implores millennials to ditch leggings for flared yoga pants

‘The flared legging versus yoga pants debate has officially commenced,’ writer says

The Independent UK

Gen-Z implores millennials to ditch leggings for flared yoga pants

‘The flared legging versus yoga pants debate has officially commenced,’ writer says

Woman & Home

14 best black swimsuits that are utterly timeless and exude 'Quiet Luxury'

A summer essential, these are the best black swimsuits to shop right now

Get all your
news in one place.

100's of premium titles.
One news app.

Woman & Home

15 best one-piece swimsuits that’ll make you want to book a vacation

The best one-piece swimsuits deliver on design, fabric and fit for a failsafe pool-side look

Woman & Home

The 28 most famous plus size models in the world - and how to follow them

These are 28 of the most famous plus size models in the world from Ashley Graham to Tess Holliday

Input

Aerie links with disability-focused Liberare for sexy, accessible intimates

Its partnership with intimates label Liberare focuses on accessibility first.

Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant. Eledon shares traded in a range of $2.89 to $3.16 on a day volume of 31.27 thousand…

Benzinga

Aerie Pharmaceuticals Begins Patient Dosing In Late-Stage Dry Eye Disease Study

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has dosed the first patient in the Phase 3 COMET-2 study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease (DED).

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.